Une personne soucieuse de sa santé, qui s'intéresse beaucoup au bien-être et aux progrès médicaux, et qui suit également l'actualité scientifique générale et, occasionnellement, les dernières nouvelles en matière d'environnement. Elle s'attache à se tenir informée des dernières recherches et tendances en matière de santé.
Vous souhaitez recevoir chaque jour la revue de presse de ce profil ?
Immunotherapy timing, diabetes breakthroughs, electric flight and Antarctic ocean data...
Lundi 8 décembre 2025 à 22:02
Health Advances & Concerns
Cancer Immunotherapy Timing Improves Survival
Research published in The Scientist shows that patients receiving checkpoint‑inhibitor therapy before 3 p.m. experience significantly longer overall survival, likely due to circadian fluctuations in immune cell activity. The meta‑analysis underscores the growing relevance of chronotherapy in oncology. The Scientist adds that aligning treatment schedules with patients’ biological clocks could become a new standard of care.
The Scientist
Promising Leukemia Drug Shows Strong Molecular Responses
STAT News reports that TERN‑701, a targeted therapy from Terns Pharmaceuticals, achieved a 64 % major molecular response in chronic myeloid leukemia patients who had exhausted multiple prior lines of treatment. The early‑stage results have drawn investor interest as the drug may rival existing Novartis blockbusters. STAT News notes the trial’s 24‑week durability, highlighting its potential to reshape leukemia management.
STAT News
Noninvasive Raman Glucose Monitor Could End Finger Pricks
Scientists at MIT have demonstrated a portable device that uses Raman spectroscopy to read blood‑glucose levels through intact skin, eliminating the need for painful finger sticks. The Scientist explains that the shoebox‑sized prototype delivered accurate readings over a four‑hour trial, marking a major step toward painless diabetes monitoring. The Scientist emphasizes the technology’s scalability for continuous, at‑home use.
The Scientist
Vitamin K Injection Refusal Surges, Raising Infant Bleed Risks
A new study highlighted in Scientific American reveals an 80 % increase in parental refusal of the newborn vitamin K shot, a prophylaxis that has prevented fatal intracranial hemorrhages for six decades. Scientific American links the trend to misinformation on social media, warning of a potential rise in preventable infant brain injuries.
Scientific American
Oral GLP‑1 Pill Cuts Weight but Triggers Nausea
STAT News details that aleniglipron, an oral GLP‑1 agonist from Structure Therapeutics, produced 12–14 % weight loss in phase‑2 trials, yet 65 % of participants reported nausea and 32 % experienced vomiting. The report stresses the need to balance efficacy with tolerability as the drug advances toward regulatory review. STAT News also notes the ongoing investigation into optimal dosing strategies.
STAT News
GLP‑1 Diabetes Drugs Disappoint in Alzheimer Trials
Two large clinical trials testing GLP‑1 agents such as semaglutide for Alzheimer’s disease failed to meet primary endpoints, according to ScienceAlert. ScienceAlert quotes endocrinologist Daniel Drucker, who calls the outcomes “very disappointing,” underscoring the difficulty of repurposing metabolic drugs for neurodegeneration.
sciencenews.org
Seniors Unplug Health Devices Over Privacy Fears
IEEE Spectrum documents a growing reluctance among older adults to use connected health wearables after concerns that personal health data could be accessed without consent. Interviews reveal that 34 % of adults over 50 cite privacy as a primary barrier, and many resort to disabling devices entirely, jeopardizing potential health benefits. IEEE Spectrum calls for “privacy‑by‑default” design to restore trust.
IEEE Spectrum
Calorie‑Restriction Study Links 30% Cut to Brain Aging Protection
ScienceAlert reports that a modest 30 % reduction in daily caloric intake may significantly shield neurons from age‑related decline, offering a practical dietary strategy to delay dementia. The study, involving mouse models and early human data, suggests that even partial calorie restriction can activate protective metabolic pathways. ScienceAlert highlights the potential for non‑pharmacological interventions in brain health.
Science Alert
Science Frontiers
Air New Zealand Tests All‑Electric and Hydrogen Planes
Popular Science reveals that Air New Zealand has launched a four‑month “intensive proving program” to evaluate battery‑electric and hydrogen‑fuel‑cell aircraft on cargo routes. While still early‑stage, the trials aim to cut aviation‑related greenhouse‑gas emissions and could pave the way for sustainable commercial flight. Popular Science notes the technical and economic hurdles that remain.
popsci.com
Antarctic Under‑Ice Robot Reveals Hidden Ocean Data
Popular Science describes an autonomous float that spent eight months beneath the Denman and Shackleton Ice Shelves, collecting unprecedented measurements of temperature, salinity, oxygen, and pH. The data provide new insights into the vulnerability of East Antarctic ice shelves to climate change. Popular Science emphasizes the robot’s role in expanding our understanding of polar ocean dynamics.
popsci.com
Environment & Climate Action
White Storks Set to Re‑establish in London’s Urban Landscape
The Guardian reports that a rewilding project will reintroduce white storks to London’s Barking and Dagenham borough in 2026, marking the species’ first breeding presence in the UK since the 15th century. The initiative aims to foster urban biodiversity and reconnect city dwellers with native wildlife. The Guardian highlights the broader significance for European conservation efforts.
The Guardian (Environnment)